Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD

Betz Halloran

Fred Hutchinson Cancer Research Center named a MIDAS Center of Excellence

Researchers at Fred Hutchinson Cancer Research Center, including several VIDD faculty, received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence. Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism. Read more »

More Featured News from VIDD »

Upcoming VIDD Events

 

Ram Savan, PhD
Tuesday, September 30

FHCRC Shared Resources
Tuesday, October 7

VIDD Faculty Stories

 

Curing chronic viral infections with Keith Jerome
It wasn’t very long ago that the idea of an HIV cure was scoffed at. The concept of a curative method for dealing with chronic viral infections, as opposed to preventative (such as vaccines) or treatment (such as antivirals), has a history of controversy among the field.

More VIDD Faculty Stories »

VIDD Publication Spotlight

 

A model for single cell gene expression variability
Cell growth is a dynamic, stochastic process. In any one homogenous cell population the individual cells are not actually all in the same phase of the cell cycle.

More VIDD News »

Find VIDD Faculty

 

International Spotlight

 

Uganda
Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs »

VIDD Announcements

 

VIDD’s Population Sciences (PS) Program has changed its name to Biostatistics, Bioinformatics, and Epidemiology (BBE). 


Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.